EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incomplete Decarboxylation of Acidic Cannabinoids in GC-MS Leads to Underestimation of the Total Cannabinoid Content in Cannabis Oils Without Derivatization

Martina Franzin iD, Rebecca Di Lenardo, Rachele Ruoso, Riccardo Addobbati

Pharmaceutics · 05.03.2025 · 17 (3) · 334

DOI: 10.3390/pharmaceutics17030334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 05.03.2025. Verfasst von Martina Franzin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Via dell'Istria 65/1, 34137 Trieste, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IRCCS "BURLO GAROFOLO", Italian Ministry of Health through the contribution given to the Institute for Maternal and Child Health IRCCS “Burlo Garofolo”, Trieste, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cannabis oil titration consists of quantification of the acidic precursors tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA) and their decarboxylated products, the active neutral cannabinoids delta-9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), and is recommended to ensure galenic preparation quality through gas and liquid chromatography coupled with mass spectrometry (GC-MS; LC-MS). Analyses by LC-MS and GC-MS involving derivatization allow for detection of acidic and neutral cannabinoids; on the contrary, GC-MS without derivatization determines only neutral cannabinoids due to high temperature-decarboxylation occurring in the injection system. However, it is not clear if decarboxylation is complete.

Methods

Different GC-MS methods with (BSTFA: TMCS and pyridine; incubation at 60 °C for 25 min) or without derivatization and an LC-MS method were developed for cannabinoid quantification. The total Δ9-THC and CBD yield of recovery were compared between the methods by testing laboratory samples with known concentrations of THCA and CBDA (total Δ9-THC and CBD: 175–351–702 ng/mL) and real cannabis oil samples (n = 6).

Results

The total Δ9-THC and CBD yield of recovery were determined using LC-MS and GC-MS with derivatization, but not using GC-MS without derivatization (decarboxylation conversion rate of about 50–60%). No high deviation (

Schlagwörter

Stichwörter der Autor:innen

GC-MSLC-MSacid formscannabinoidscannabis oildecarboxylation

Autor:innen und Institutionen

  • Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Via dell'Istria 65/1, 34137 Trieste, Italy.

ORCID-Profile: Martina Franzin

Förderung

  • IRCCS "BURLO GAROFOLO"
  • Italian Ministry of Health through the contribution given to the Institute for Maternal and Child Health IRCCS “Burlo Garofolo”, Trieste, Italy

Zitieren

APA

Franzin, M., Di Lenardo, R., Ruoso, R., & Addobbati, R. (2025). Incomplete Decarboxylation of Acidic Cannabinoids in GC-MS Leads to Underestimation of the Total Cannabinoid Content in Cannabis Oils Without Derivatization. Pharmaceutics, 17(3), 334. https://doi.org/10.3390/pharmaceutics17030334

Vancouver

Franzin M, Di Lenardo R, Ruoso R, Addobbati R. Incomplete Decarboxylation of Acidic Cannabinoids in GC-MS Leads to Underestimation of the Total Cannabinoid Content in Cannabis Oils Without Derivatization. Pharmaceutics. 2025;17(3):334. doi:10.3390/pharmaceutics17030334

BibTeX
@article{Franzin2025,
  author = {Franzin, Martina and Di Lenardo, Rebecca and Ruoso, Rachele and Addobbati, Riccardo},
  title = {Incomplete Decarboxylation of Acidic Cannabinoids in GC-MS Leads to Underestimation of the Total Cannabinoid Content in Cannabis Oils Without Derivatization},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {334},
  doi = {10.3390/pharmaceutics17030334}
}
Kostenlos starten →